See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of ...

Photobiomodulation Therapy (PBMT) uses red and near-infrared light to enhance cellular repair, reduce inflammation, and support neurological and skin health. Learn how it works, how it's different ...

Vutrisiran improved all-cause mortality and recurrent CV independent of disease severity in cardiac amyloidosis. Regardless of cutoffs, vutrisiran also improved various health and quality of life ...

Phase 3 – REVEAL study with 124 I-evuzamitide in patients with suspected cardiac amyloidosis is ongoing by Brigham and Women’s Hospital, Boston, MA. AT-05 (99mTc-p5+14), a radiotracer ...

Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...

Both early-onset and late-onset Alzheimer's disease start with amyloid slowly collecting in the brain two decades before memory and thinking problems arise. Further, all trial results from these ...

The findings suggest -- for the first time in a clinical trial -- that early treatment to remove amyloid plaques from the brain many years before symptoms arise can delay the onset of Alzheimer's ...

Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by binding to and removing beta-amyloid plaques through various mechanisms ...

An early look at the phase 1b/2a data showed amyloid levels fell below a disease threshold in 81% of patients after 28 weeks. The Swiss drugmaker has identified the speed at which amyloid is ...

McDade said this study has the longest-running data for any patients who started amyloid-lowering biologics while they were still free of symptoms. “We think that there’s a delay in the ...

and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, is the study director of an international clinical trial that finds an anti-amyloid drug can delay the onset of cognitive ...